PALOMINO LABS INC (PALX) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PALX SEC filings page.
This page shows PALOMINO LABS INC (PALX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financing-led expansion enlarged Palomino’s balance sheet while operating losses and cash outflows continued.
From FY2024 to FY2025, total assets rose from$138K to$8.4M as financing cash flow reached$9.3M , indicating that the balance-sheet expansion was not produced by operations. Shares outstanding reached 18.9M while operating cash flow was-$1.3M , reinforcing external financing as the central growth mechanic.
Balance-sheet posture changed materially: FY2025 liabilities were
The visible expense base is dominated by SG&A: FY2025 operating loss was
Financial Health Signals
PALOMINO LABS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
PALOMINO LABS INC passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
PALOMINO LABS INC reported a net loss of $3.2M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
PALOMINO LABS INC's EBITDA was -$1.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. Against the prior quarter it is down 9.0%.
PALOMINO LABS INC reported -$1.4M in net income in Q2 2026. This represents a decrease of 450.5% from the same quarter a year earlier. Against the prior quarter it is down 9.8%.
PALOMINO LABS INC earned -$0.06 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 14.3%.
Not reported for Q2 2026.
Cash & Balance Sheet
PALOMINO LABS INC recorded an outflow of $2.1M in free cash flow in Q2 2026, representing a cash shortfall after capex. Against the prior quarter it is down 43.8%.
PALOMINO LABS INC held $19.4M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
PALOMINO LABS INC's ROE was -6.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 11.1 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
PALOMINO LABS INC invested $669K in research and development in Q2 2026. Against the prior quarter it is up 52.6%.
PALOMINO LABS INC invested $941K in capex in Q2 2026, funding long-term assets and infrastructure. Against the prior quarter it is up 195.7%.
Not reported for Q2 2026.
PALX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $669K | $438K | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $697K+106.4% | $805K+4417.4% | N/A | $1.6M+129958.5% | $337K | $18K | N/A | $1K |
| Operating Income | -$1.4M-304.6% | -$1.2M-6875.6% | N/A | -$1.6M-129958.5% | -$337K | -$18K | N/A | -$1K |
| EBITDA | -$1.4M | -$1.2M | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | $8K | $14K | N/A | N/A |
| Net Income | -$1.4M-450.5% | -$1.2M | N/A | -$1.8M | $389K+112448.3% | N/A | N/A | N/A |
| EPS (Basic) | -$0.06-140.0% | -$0.07+84.1% | $0.41+5212.5% | -$0.54 | $0.15+2600.0% | -$0.44-4300.0% | -$0.01-14.3% | $0.00+100.0% |
| EPS (Diluted) | -$0.06 | -$0.07 | $0.41 | -$0.54 | $0.15+2600.0% | -$0.44-4300.0% | -$0.01-14.3% | $0.00+100.0% |
| Diluted Shares (Avg) | 22M | 19M | N/A | 3M | 3M-48.3% | 2M-55.5% | N/A | 2M-66.8% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.
PALX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.0M+1089.2% | $7.4M+40304.5% | $8.4M+6006.2% | $8.3M+2581502.8% | $1.8M+549417.4% | $18K+4694.7% | $138K-1.0% | $322-15.3% |
| Current Assets | $19.6M+1023.2% | $6.8M+37361.6% | $8.4M+6006.2% | N/A | $1.7M+541653.4% | $18K+4694.7% | $138K+36248.7% | $322-15.3% |
| Cash & Equivalents | $19.4M+1028.1% | $6.7M | $8.1M+5931.2% | $7.9M | $1.7M | N/A | $135K-3.5% | N/A |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | N/A |
| Total Liabilities | $476K-78.5% | $352K-65.1% | $336K+115.1% | $999K+11429.3% | $2.2M+95001.5% | $1.0M+5304.4% | $156K+10.4% | $9K-89.0% |
| Current Liabilities | $369K+182.6% | $229K-32.1% | $336K+5131.8% | $999K | $131K | $337K | $6K+24.0% | N/A |
| Non-Current Liabilities | $107K-94.9% | $123K-81.7% | $0-100.0% | $0 | $2.1M | $673K | $150K+9.9% | N/A |
| Total Equity | $20.6M+4698.5% | $7.0M+806.9% | $8.1M+44335.2% | $7.3M+87763.3% | -$447K-22161.6% | -$992K-5317.1% | -$18K0.0% | -$8K+89.4% |
| Retained Earnings | -$5.8M-842.8% | -$4.4M-1286.0% | -$3.2M-17223.1% | -$2.4M-999.0% | -$614K-215.2% | -$319K-95.8% | -$18K-747.1% | -$222K-180.3% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
PALX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.1M-1233.8% | -$1.1M-36681.5% | -$894K-15586.9% | -$310K-269458.3% | -$84K | $3K | -$6K+90.0% | $115 |
| Depreciation & Amortization | $12K | $3K | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock-Based Compensation | $101K-35.1% | N/A | N/A | $1.3M | $155K | N/A | N/A | N/A |
| Capital Expenditures | $941K | $318K | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$2.1M | -$1.4M | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$941K | -$318K | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $14.9M+789.3% | -$30K-150100.0% | $1.1M+673.1% | $6.5M | $1.7M | $20 | $145K+155.0% | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
PALX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -6.6% | -17.7% | N/A | -24.9% | N/A | N/A | N/A | N/A |
| Return on Assets | -6.5%-28.5pp | -16.9% | N/A | -21.9% | 22.0%-85.4pp | N/A | N/A | N/A |
| Current Ratio | 53.12+39.7x | 29.82+29.8x | 25.07+3.6x | N/A | 13.37 | 0.05 | 21.48+21.4x | N/A |
| Debt-to-Equity | 0.02 | 0.05 | 0.04 | 0.14 | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Where PALOMINO LABS INC Ranks
Frequently Asked Questions
Is PALOMINO LABS INC profitable?
No, PALOMINO LABS INC (PALX) reported a net income of -$3.2M in fiscal year 2025.
What is PALOMINO LABS INC's return on equity (ROE)?
PALOMINO LABS INC (PALX) has a return on equity of -39.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is PALOMINO LABS INC's operating cash flow?
PALOMINO LABS INC (PALX) recorded an outflow of $1.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are PALOMINO LABS INC's total assets?
PALOMINO LABS INC (PALX) had $8.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is PALOMINO LABS INC's current ratio?
PALOMINO LABS INC (PALX) had a current ratio of 25.07 as of fiscal year 2025, which is generally considered healthy.
What is PALOMINO LABS INC's debt-to-equity ratio?
PALOMINO LABS INC (PALX) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is PALOMINO LABS INC's return on assets (ROA)?
PALOMINO LABS INC (PALX) had a return on assets of -37.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is PALOMINO LABS INC's Piotroski F-Score?
PALOMINO LABS INC (PALX) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are PALOMINO LABS INC's earnings high quality?
PALOMINO LABS INC (PALX) reported a net loss of $3.2M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.